Abemaciclib and Liquid Biopsies: a Guide to Future Early Breast Cancer Treatment - A COST-EFFECTIVENESS ANALYSIS OF ADDITIONAL ABEMACICLIB AND THE USE OF LIQUID BIOPSIES IN HIGH-RISK HORMONE RESPONSIVE, HER2 NEGATIVE EARLY BREAST CANCER TREATMENT

Additional Metadata
Keywords	Cost-effectiveness analysis;abemaciclib;liquid biopsies
Thesis Advisor	Uyl-de Groot, C.A.
Persistent URL	hdl.handle.net/2105/62508
Series	Master Health Economics, Policy and Law
Organisation	Erasmus School of Health Policy & Management
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Schoubroeck, H.M. van. (2021, June 25). Abemaciclib and Liquid Biopsies: a Guide to Future Early Breast Cancer Treatment - A COST-EFFECTIVENESS ANALYSIS OF ADDITIONAL ABEMACICLIB AND THE USE OF LIQUID BIOPSIES IN HIGH-RISK HORMONE RESPONSIVE, HER2 NEGATIVE EARLY BREAST CANCER TREATMENT. Master Health Economics, Policy and Law. Retrieved from http://hdl.handle.net/2105/62508

Publication